Source link : https://www.yourblogdomain.com/2024/12/13/ema-recommends-seladelpar-for-primary-biliary-cholangitis/
Source link : https://www.newshealth.biz/health-news/ema-recommends-seladelpar-for-primary-biliary-cholangitis/ The European Medicines Agency (EMA) has recommended granting marketing authorization for Seladelpar Gilead (seladelpar lysine dihydrate) to treat primary biliary cholangitis (PBC). PBC is a chronic autoimmune liver disease marked by inflammation and progressive destruction of the small bile ducts within the liver. This leads to the accumulation of toxic bile […]
Author : yourblogdomain
Publish date : 2024-12-13 14:53:14
Copyright for syndicated content belongs to the linked Source.